Since 2010, Greg Zarbis-Papastoitsis has been working in Eleven Biotherapeutics. This expert is a high-skilled Senior Director of Protein Production with over 17 years of work experience. According to Greg's CV and work profile, the professional has worked at more than eight companies with numerous backgrounds and gained various skills. Greg attended school at the Boston University School of Medicine from 1990 to 1993. Greg Zarbis-Papastoitsis can be found in Boston, Massachusetts – where the professional currently lives. You can search for Greg Zarbis-Papastoitsis's e-mail and phone. We can also provide you exhaustive contact information upon request.
Name variants:
Gregory Papastoitsis
Last updated Feb 16, 2024
Contact Information
Workplace
Senior Director of Protein Production
Cambridge, MA
Industry
Biotechnology, Mfg Pharmaceutical Preparations Commercial Physical Research, Pharmaceutical Preparations Commercial Physical Research
Colleagues
Work History
Senior Director of Protein Production
"Eleven Biotherapeutics is focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics to improve human health and...
from Jul 2010
Senior Director of BioProcess R&D
Establish Breakthrough Processes for the Production of Recombinant Molecules using High Titer and High Cell Density PER.C6 Cell Lines. The Downstream Processes Includes Single Use Steps and ...
2006 — Jul 2010
Associate Director Process Development
Developed a Pre-Clinical and then Clinical Enabling Process for the Manufacturing of recombinant long lasting Factor IX, a Blood-Clotting Factor. Ensured that Necessary In-Process and Releas...
2004 — 2006
Senior Scientist Technical Operations
One of the Lead Scientists that Designed the 2nd Generation Manufacturing Process for the HUMIRA Mab, an anti-TNF Molecule, and Enabled the Technology Transfer to a New Manufacturing Facilit...
2003 — 2004
Senior Scientist Process Development
Lead the Development of Downstream Processes for Recombinant Proteins, Monoclonal Antibodies, and Antibody Conjugates, using Conventional, Scaleable Techniques. Lead Effort to Design and Equ...
1999 — 2003
Senior Principal Investigator
Developed Intermediate Processes (Pre-Clinical) for a Recombinant Interferon Receptor and a Recombinant Ig Fusion Molecule, using Conventional Chromatography Techniques. Participated in Disc...
1996 — 1999
Process Scientist III
One of the Key Scientist that Developed a Commercial Enabling Process for the Recombinant IL-2 Fusion Toxin Including the Development and Scale-Up of a High Resolution Chromatography Step fo...
1994 — 1996
Scientist
Developed Steps to Extract, Refold, and Purify Recombinant Platelet Factor-4 for Clinical Production. Scaled-Up the Methods and Transferred them to the Manufacturing Department for the Produ...
1993 — 1994
Education
1990 — 1993
1986 — 1990
Occupations
Executive
Senior Director
Engineer
Scientist
Biotechnology Professional
Senior Manager
Operations Manager
Biologist
Biological Scientist
Skills
Expertise in Process Development and Scale-Up of MAbs
Antibody Conjugates
Fusion Proteins
and Enzymes
Experience Transferring Processes to cGMP Manufacturing Facilities
Writing in Support of Regulatory Submissions
Evaluation of CMO and CRO Organizations
Experience Working with Partners and Leading Technical Teams and Personnel
FAQs about Greg Zarbis-Papastoitsis
What is the main profession of Greg Zarbis-Papastoitsis?
Greg is a Biotechnology.
What are the main profession of Greg?
These person's professions are Executive and Senior Director
Where does Greg Zarbis-Papastoitsis currently live?
Greg Zarbis-Papastoitsis currently lives in Boston, Massachusetts.
Where did Greg Zarbis-Papastoitsis work?
Greg Zarbis-Papastoitsis worked at Eleven Biotherapeutics, PERCIVIA.
What education does Greg Zarbis-Papastoitsis have?
Greg studied at the Boston University School of Medicine from 1990 to 1993.
What are special skills of Greg Zarbis-Papastoitsis?
This person has skills in the following areas: Expertise in Process Development and Scale-Up of MAbs, Antibody Conjugates, Fusion Proteins, and and Enzymes.